Advertisements


Tris Pharma recalls infant ibuprofen for being too strong, risking permanent renal injury

Tris Pharma says it is voluntarily recalling some lots of infant ibuprofen for being too strong, and putting users at risk of being vulnerable to permanent renal injury......»»

Category: topSource: marketwatchDec 6th, 2018

Infant ibuprofen recalled from Walmart, CVS, Family Dollar

Three lots of liquid ibuprofen for infants sold as store brands by Walmart, CVS and Family Dollar have been recalled by the manufacturer, Tris Pharma, Inc. The recalled lots of the product have been found to potentially have higher concentrations.....»»

Category: topSource: bizjournalsDec 7th, 2018

Infant Ibuprofen Recalled From Walmart, CVS, Family Dollar Over Fears of High Dosage

Tris Pharma, Inc. issued a recall on three lots of infant ibuprofen. The New Jersey pharmaceutical company Tris Pharma, Inc. has issued a recall on three l.....»»

Category: europeSource: fortuneDec 6th, 2018

Infant Ibuprofen Recall Hits Walmart, CVS, Family Dollar Stores

Drugmaker Tris Pharma has recalled a baby ibuprofen medication sold at Walmart, CVS, and Family Dollar stores under house brand names......»»

Category: blogSource: 247wallstDec 6th, 2018

Tonix Pharma Rips Higher After FDA OKs Study Design For PTSD Drug

Tonix Pharmaceuticals (NASDAQ: TNXP) shares — which began to trade on a split-adjusted basis Wednesday after a decision to enact a 1-for-10 reverse stock split — were seeing strong buyin read more.....»»

Category: blogSource: benzingaNov 29th, 2018

Walmart Recalls Thousands of Ozark Trail Axes Over Injury Concerns

There have been two reports of problems. Walmart has recalled $8 camp axes. The company said .....»»

Category: europeSource: fortuneOct 5th, 2018

Chopped from the shelves: Walmart recalls 246,000 axes for injury hazard

Walmart is recalling 246,000 Ozark Trail camp axes. The retail giant says the axe head can detach from the handle, pos.....»»

Category: topSource: usatodayOct 4th, 2018

Walmart recalls camp axes due to injury risk

Walmart Inc. (NYSE: WMT) and the U.S. Consumer Product Safety Commission have issued a recall of roughly 246,000 Ozark Trail camp axes due to potential injury risk. The recall, issued on Wednesday, comes after the commission received two reports.....»»

Category: topSource: bizjournalsOct 3rd, 2018

Your Daily Pharma Scoop: Cellectar Bio Shows Encouraging Early Data; Arena"s Ralinepag Posts Strong PAH Results

Your Daily Pharma Scoop: Cellectar Bio Shows Encouraging Early Data; Arena"s Ralinepag Posts Strong PAH Results.....»»

Category: topSource: seekingalphaOct 3rd, 2018

Horizon Pharma target raised to $23 on "strong" Q2 at Jefferies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

Textron recalls about 255 snowmobiles due to injury hazard

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

Bayer to stop sales of Essure implanted birth control device tied to injuries

The maker of a permanent contraceptive implant subject to thousands of injury reports from women and repeated safety restrictions by regulators says it will stop selling the device in the U.S.      .....»»

Category: topSource: usatodayJul 20th, 2018

Pharma Stock Roundup: JNJ & NVS" Q2 Earnings, FDA Approvals

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»

Category: personnelSource: nytJul 20th, 2018

Johnson & Johnson profit beat fueled by strength in pharma business

Johnson & Johnson topped analysts' estimates for quarterly profit and revenue on Tuesday, as strong demand for cancer drugs Zytiga and Darzalex more than made up for declining sales of blockbuster treatment Remicade......»»

Category: topSource: reutersJul 17th, 2018

Mid-Day Market Update: Lululemon Surges After Strong Q1 Results; Kitov Pharma Shares Plunge

Midway through trading Friday, the Dow traded up 0.76 percent to 24,600.23 while the NASDAQ climbed 1.23 percent to 7,533.59. The S&P also rose, gaining 0.91 percent to 2,729.96. read more.....»»

Category: blogSource: benzingaJun 1st, 2018

Strong growth outlook for Aurobindo Pharma after Q4 slip

Large US portfolio, lower price erosion expected to drive earnings.....»»

Category: topSource: business-standardMay 29th, 2018

Cara Therapeutics Shares Jump On Licensing Deal For Pruritis Treatment

Shares of Cara Therapeutics Inc (NASDAQ: CARA) are surging to a three-month high in reaction to a licensing agreement the biotech company announced with Vifor Fresenius Medical Care Renal Pharma. read more.....»»

Category: blogSource: benzingaMay 23rd, 2018

Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma"s Gene Therapy Data

Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma"s Gene Therapy Data.....»»

Category: topSource: seekingalphaMay 21st, 2018

Mid-Afternoon Market Update: Precipio Surges Following Strong Preliminary Q1 Results; aTyr Pharma Shares Slide

Toward the end of trading Monday, the Dow traded up 0.34 percent to 24,915.39 while the NASDAQ climbed 0.19 percent to 7,417.21. The S&P also rose, gaining 0.11 percent to 2,730.74. read more.....»»

Category: blogSource: benzingaMay 14th, 2018

Vertex (VRTX) Q1 Earnings Beat on Strong CF Products Sales

Vertex Pharma (VRTX.....»»

Category: worldSource: nytApr 27th, 2018

Polaris recalls 10,900 Ranger XP ROVs due to injury hazard

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2018